Aurora Cannabis (ACB) Long-Term Investments (2018 - 2023)
Aurora Cannabis (ACB) reported Long-Term Investments of $5.4 million for Q1 2023, up 486.97% quarter-over-quarter from $913511.6 in Q4 2022.
Aurora Cannabis (ACB) Long-Term Investments (2018 - 2023) Analysis & Trends
Aurora Cannabis (ACB) has 6 years of Long-Term Investments data on file, last reported at $5.4 million in Q1 2023.
- Long-Term Investments for Q1 2023 came in at $5.4 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was $5.4 million (changed N/A YoY), and the FY2023 annual result was $5.4 million, changed N/A from the prior year.
- Long-Term Investments grew to $5.4 million in Q1 2023 per ACB's latest filing, from $913511.6 in the prior quarter.
- Over five years, Long-Term Investments peaked at $88.8 million in Q2 2019 and troughed at $235109.3 in Q2 2021.
- A 5-year average of $18.0 million and a median of $2.5 million in 2022 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2019 and 2020: Long-Term Investments soared 11718.32% in 2019, then tumbled 99.1% in 2020.
- A 5-year view of Long-Term Investments shows it stood at $52.8 million in 2019, then slumped by 98.68% to $694951.5 in 2020, then soared by 635.17% to $5.1 million in 2021, then plunged by 82.12% to $913511.6 in 2022, then soared by 486.97% to $5.4 million in 2023.
- Business Quant data shows ACB's Long-Term Investments at $5.4 million in Q1 2023, $913511.6 in Q4 2022, and $948465.1 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.90 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 5.36 Mn |
| Dec 31, 2022 | 913,511.65 |
| Sep 30, 2022 | 948,465.11 |
| Jun 30, 2022 | 946,699.17 |
| Dec 31, 2021 | 5.11 Mn |
| Sep 30, 2021 | 4.04 Mn |
| Jun 30, 2021 | 235,109.35 |
| Mar 31, 2021 | 247,301.03 |
| Dec 31, 2020 | 694,951.53 |
| Sep 30, 2020 | 778,939.77 |
| Jun 30, 2020 | 13.06 Mn |
| Mar 31, 2020 | 26.74 Mn |
| Dec 31, 2019 | 52.78 Mn |
| Sep 30, 2019 | 86.97 Mn |
| Jun 30, 2019 | 88.82 Mn |
| Mar 31, 2019 | 721,109.81 |
| Dec 31, 2018 | 726,557.38 |
| Sep 30, 2018 | 735,901.79 |
| Jun 30, 2018 | 259.25 Mn |
| Mar 31, 2018 | -83.14 Mn |